Vitamin D's reputation is built on bone health and immunity. But for the past decade, a growing body of research has been investigating its influence on the brain — cognitive function, mood, dementia risk. What does the science actually say, beyond supplement marketing claims?
In this edition of The Nutrition Lab, we review the available evidence, its limitations, and what it concretely means for your supplementation strategy.
Why the Brain Depends on Vitamin D
Vitamin D receptors (VDRs) are present in multiple brain regions, including the hippocampus (memory center) and prefrontal cortex. The brain also produces its own active form of vitamin D from circulating 25-OH-D3, suggesting a direct and not merely systemic role.
Vitamin D modulates production of neurotrophins like BDNF (brain-derived neurotrophic factor), involved in neuroplasticity. It also influences serotonin and dopamine synthesis through enzymes it regulates — a mechanism potentially linked to mood regulation.
What Observational Studies Show
The epidemiological data is consistent: individuals with 25-OH-D3 levels below 20 ng/mL show significantly lower cognitive scores than those above 30 ng/mL, with higher risk of accelerated cognitive decline and Alzheimer's disease.
A 2024 meta-analysis of 38 observational studies (280,000+ participants) confirmed the association between vitamin D deficiency and all-cause dementia risk (odds ratio: 1.42). Solid data — but it doesn't establish causation.
The Problem With Randomized Trials
Here's where it gets complicated. Randomized controlled trials (RCTs) — the gold standard — have been disappointing. The large VITAL trial (25,000 participants, 5 years, 2,000 IU/day) showed no significant cognitive benefit for vitamin D supplementation vs. placebo in adults with normal baseline levels.
Several factors may explain this gap: RCT participants often had sufficient baseline levels (selection bias), tested doses may have been too low for severely deficient individuals, and brain effects could take decades to manifest — a timescale hard to capture in an RCT.
The Threshold Question
The emerging consensus: cognitive benefits from vitamin D are primarily linked to correcting deficiency (
Form matters too. Vitamin D3 (cholecalciferol) outperforms D2 (ergocalciferol) for raising blood levels. Combined with vitamin K2 (MK-7), it may optimize calcium utilization and reduce arterial calcification risk at higher doses.
What This Means for Your Supplementation
Practical recommendation: measure your 25-OH-D3 before supplementing. If you're below 30 ng/mL, 1,000–2,000 IU/day is reasonable. If below 20 ng/mL (frank deficiency), 3,000–4,000 IU/day for 3 months, then retest.
If you're in Northern Europe or largely indoors: systematic supplementation from September to March is justified for most adults, regardless of the primary reason (bone, immunity, or cognitive health).
Vitamin D and the brain: solid epidemiological association, plausible biological mechanisms, disappointing RCTs. The most honest conclusion is also the most practical: correcting deficiency is worthwhile for the brain, as it is for the rest of your physiology. Supplementing beyond normalization doesn't appear to add proven cognitive benefit.